Company Profile
  • Company Profile
  • Management Team
  • Vision & Mission
  • Milestones
  • Investors
  •         SIMR is an innovation-oriented biopharmaceutical company dedicated to the development of new drugs for pain and other nervous system diseases. Since its establishment in 2014, it has built up the capability in discovery (cell biology, pharmaceutical chemistry, process research, formulation research, quality research, pharmacological efficacy evaluation) and clinical development. From 2016 to 2018, SIMR completed the financing of tens of millions RMB at pre-A round and over 100 million RMB at A round.